MYC and B-cell non-Hodgkin lymphoma: The transgenic and knock-in mouse models in c-Myc driven by immunoglobulin heavy chain (IgH) locus enhancer highlights the critical role of c-Myc dysregulation in the development of B cell lymphoma 9, 10.